Alere Pays $33.2M To Settle False Claims Suit Involving Fast Blood Chemistry Tests

(March 27, 2018, 10:09 AM EDT) -- BALTIMORE — Alere Inc. and subsidiary Alere San Diego (Alere) have agreed to pay $33.2 million to settle False Claims Act allegations that they sold federal health programs rapid blood chemistry test devices that the defendants knew were unreliable, the U.S. Justice Department announced March 23 (United States, ex rel. Amanda Wu v. Alere San Diego, et al., No. 11-1808, D. Md.)....

Related Sections